Menu
GeneBe

CUL7

cullin 7, the group of Cullins

Basic information

Region (hg38): 6:43037616-43053943

Previous symbols: [ "KIAA0076" ]

Links

ENSG00000044090NCBI:9820OMIM:609577HGNC:21024Uniprot:Q14999AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • 3M syndrome 1 (Definitive), mode of inheritance: AR
  • 3M syndrome 1 (Definitive), mode of inheritance: AR
  • 3-M syndrome (Supportive), mode of inheritance: AR
  • 3M syndrome 1 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Three M syndrome 1ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Musculoskeletal16142236; 17675530; 19225462; 21166787; 22624670; 22974575

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CUL7 gene.

  • not provided (516 variants)
  • 3M syndrome 1 (170 variants)
  • Inborn genetic diseases (65 variants)
  • not specified (32 variants)
  • 3-M syndrome (9 variants)
  • CUL7-related condition (3 variants)
  • - (1 variants)
  • Growth delay;Short stature (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CUL7 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
29
clinvar
80
clinvar
14
clinvar
123
missense
1
clinvar
4
clinvar
272
clinvar
10
clinvar
12
clinvar
299
nonsense
26
clinvar
2
clinvar
2
clinvar
30
start loss
0
frameshift
22
clinvar
7
clinvar
3
clinvar
32
inframe indel
1
clinvar
3
clinvar
1
clinvar
5
splice donor/acceptor (+/-2bp)
2
clinvar
7
clinvar
9
splice region
12
12
1
25
non coding
12
clinvar
38
clinvar
24
clinvar
74
Total 51 21 321 129 50

Highest pathogenic variant AF is 0.0000853

Variants in CUL7

This is a list of pathogenic ClinVar variants found in the CUL7 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
6-43037617-T-C 3M syndrome 1 Uncertain significance (Jan 12, 2018)356812
6-43037631-T-C 3M syndrome 1 Uncertain significance (Jan 13, 2018)356813
6-43037692-C-A Uncertain significance (Oct 24, 2022)1936926
6-43037692-C-T 3M syndrome 1 Uncertain significance (Jul 10, 2023)909227
6-43037697-G-A not specified • 3M syndrome 1 Benign (Jan 25, 2024)282943
6-43037705-A-C Inborn genetic diseases Uncertain significance (Feb 21, 2022)286956
6-43037713-G-A 3M syndrome 1 Uncertain significance (Dec 21, 2022)356814
6-43037744-G-A 3M syndrome 1 Uncertain significance (Apr 24, 2022)356815
6-43037744-G-C 3M syndrome 1 Uncertain significance (Aug 26, 2019)1027894
6-43037754-CTG-C 3M syndrome 1 Uncertain significance (Sep 13, 2019)2440629
6-43037756-G-A not specified Uncertain significance (Dec 21, 2022)1878356
6-43037756-G-T Inborn genetic diseases Uncertain significance (Feb 22, 2023)2487452
6-43037774-G-A Uncertain significance (Aug 12, 2021)1401243
6-43037774-G-T Uncertain significance (Jan 06, 2023)2876123
6-43037813-C-T 3M syndrome 1 Uncertain significance (Jan 12, 2018)909228
6-43037830-A-G Uncertain significance (Nov 27, 2023)2051935
6-43037834-T-G Inborn genetic diseases Uncertain significance (Oct 24, 2023)2136666
6-43037848-T-C Uncertain significance (Feb 10, 2021)1443447
6-43037849-A-G Uncertain significance (Aug 25, 2017)593726
6-43037850-G-A 3M syndrome 1 Benign/Likely benign (Feb 01, 2024)356816
6-43037866-C-T Inborn genetic diseases Uncertain significance (Jan 04, 2022)1384695
6-43037868-G-A CUL7-related disorder Likely benign (Apr 01, 2022)1909748
6-43037871-G-A not specified Benign/Likely benign (Oct 06, 2023)502470
6-43037873-C-CA - no classification for the single variant (-)1012245
6-43037878-C-T Inborn genetic diseases Uncertain significance (Aug 13, 2021)2363388

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CUL7protein_codingprotein_codingENST00000535468 2616329
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.59e-211.0012564701011257480.000402
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.5439591.01e+30.9520.000065311513
Missense in Polyphen310339.810.912283945
Synonymous-0.2124304241.010.00002663706
Loss of Function3.594782.00.5730.00000460878

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001570.00156
Ashkenazi Jewish0.0001990.000198
East Asian0.0006520.000653
Finnish0.00004620.0000462
European (Non-Finnish)0.0002230.000220
Middle Eastern0.0006520.000653
South Asian0.0007280.000719
Other0.0004900.000489

dbNSFP

Source: dbNSFP

Function
FUNCTION: Core component of the 3M and Cul7-RING(FBXW8) complexes, which mediates the ubiquitination of target proteins. Core component of the 3M complex, a complex required to regulate microtubule dynamics and genome integrity. It is unclear how the 3M complex regulates microtubules, it could act by controlling the level of a microtubule stabilizer (PubMed:24793695). Interaction with CUL9 is required to inhibit CUL9 activity and ubiquitination of BIRC5 (PubMed:24793696). Core component of a Cul7-RING ubiquitin-protein ligase with FBXW8, which mediates ubiquitination and consequent degradation of target proteins such as GORASP1, IRS1 and MAP4K1/HPK1 (PubMed:21572988, PubMed:24362026). Ubiquitination of GORASP1 regulates Golgi morphogenesis and dendrite patterning in brain (PubMed:21572988). Mediates ubiquitination and degradation of IRS1 in a mTOR-dependent manner: the Cul7-RING(FBXW8) complex recognizes and binds IRS1 previously phosphorylated by S6 kinase (RPS6KB1 or RPS6KB2) (PubMed:18498745). The Cul7-RING(FBXW8) complex also mediates ubiquitination of MAP4K1/HPK1: recognizes and binds autophosphorylated MAP4K1/HPK1, leading to its degradation, thereby affecting cell proliferation and differentiation (PubMed:24362026). Acts as a regulator in trophoblast cell epithelial-mesenchymal transition and placental development (PubMed:20139075). Does not promote polyubiquitination and proteasomal degradation of p53/TP53 (PubMed:16547496, PubMed:17332328). While the Cul7-RING(FBXW8) and the 3M complexes are associated and involved in common processes, CUL7 and the Cul7-RING(FBXW8) complex may be have additional functions. {ECO:0000269|PubMed:16547496, ECO:0000269|PubMed:17332328, ECO:0000269|PubMed:18498745, ECO:0000269|PubMed:20139075, ECO:0000269|PubMed:21572988, ECO:0000269|PubMed:24362026, ECO:0000269|PubMed:24793695, ECO:0000269|PubMed:24793696}.;
Disease
DISEASE: 3M syndrome 1 (3M1) [MIM:273750]: An autosomal recessive disorder characterized by severe pre- and postnatal growth retardation, facial dysmorphism, large head circumference, and normal intelligence and endocrine function. Skeletal changes include long slender tubular bones and tall vertebral bodies. {ECO:0000269|PubMed:16142236, ECO:0000269|PubMed:17675530, ECO:0000269|PubMed:23018678}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Ubiquitin mediated proteolysis - Homo sapiens (human);XBP1(S) activates chaperone genes;Post-translational protein modification;Metabolism of proteins;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Neddylation (Consensus)

Recessive Scores

pRec
0.123

Intolerance Scores

loftool
0.253
rvis_EVS
-1.53
rvis_percentile_EVS
3.39

Haploinsufficiency Scores

pHI
0.166
hipred
Y
hipred_score
0.711
ghis
0.566

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.754

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Cul7
Phenotype
adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); respiratory system phenotype; embryo phenotype; skeleton phenotype;

Gene ontology

Biological process
microtubule cytoskeleton organization;mitotic cytokinesis;vasculogenesis;epithelial to mesenchymal transition;placenta development;proteolysis;ubiquitin-dependent protein catabolic process;Golgi organization;regulation of mitotic nuclear division;viral process;protein ubiquitination;IRE1-mediated unfolded protein response;post-translational protein modification;positive regulation of dendrite morphogenesis
Cellular component
anaphase-promoting complex;cytoplasm;Golgi apparatus;centrosome;cytosol;Cul7-RING ubiquitin ligase complex;perinuclear region of cytoplasm;3M complex
Molecular function
protein binding;ubiquitin protein ligase binding